Orthopedic Group Partnership Agreement: What to Read and Negotiate Before You Sign

The buy-in offer gives you the price. The partnership agreement determines what you actually own, how much you'll receive each year, what happens if you become disabled, and whether you can be forced to sell your equity to a private equity buyer you never chose. Most surgeons spend more time evaluating the buy-in ROI than the agreement that governs it for the next 20 years.

Note: This guide covers the financial and structural dimensions of orthopedic group partnership agreements. It is not legal advice. Before signing any partnership, operating, or shareholder agreement, retain a healthcare transactional attorney licensed in your state.

Why the agreement matters more than the buy-in price

When surgeons evaluate a partnership track offer, the analysis almost always starts with the buy-in cost: what does the equity stake cost, what's the break-even timeline, what are the expected distributions? That analysis is important — the partnership buy-in analyzer models the 10-year financial comparison — but it only tells you whether the economics are attractive in the normal case.

The partnership agreement determines everything outside the normal case:

• What do you own if the group decides to admit three new partners who each dilute your equity?
• What happens to your equity if you become disabled and can no longer operate?
• What buyout formula applies when you eventually leave — book value of hard assets, or a multiple of earnings?
• What vote percentage can force you to sell your equity to a private equity buyer against your will?
• Can the group make you contribute another $200K in a capital call for a new facility?

These provisions compound financially over a career. A below-market redemption formula costs more at exit than you saved by accepting a lower buy-in. A drag-along at 60% means six of ten partners can sell your equity without your consent. Understanding the agreement is the other half of the buy-in analysis.

Ownership structure and equity classes

Orthopedic group partnerships typically structure equity in one of three ways:

Single-class equal ownership

Every full partner holds an equal unit or percentage interest. Governance is 1 partner = 1 vote; distributions are split equally (or proportional to productivity, depending on the compensation model). Most common in smaller groups of 4–8 surgeons who started the practice together.

Multi-class with founder equity

Founder partners hold Class A interests with enhanced governance rights; newer partners hold Class B interests with full economic participation but limited voting power. Common in practices where founders have built significant ASC equity and want to retain control over major decisions even as they admit new partners.

Tiered equity with phased buy-in

Associates buy in over 3–5 years, reaching full equity proportionally as capital contributions are made. During the vesting period, economic and voting rights may be pro-rated or deferred. If you're in year two of a five-year buy-in, confirm what rights you have now — you may have full voting rights, partial rights, or none until fully paid in.

Capital accounts — how your ownership value is tracked

Each partner's ownership stake is maintained through a capital account — a running ledger of contributions, distributions, and allocated profits and losses. Capital account mechanics matter at three moments: when you join (your initial contribution establishes your opening balance), annually (allocated income adjusts it), and at exit (your capital account balance is often the starting point for the buyout calculation).

Two things to verify:

1. Whether the buyout formula uses capital account value or a separate appraisal formula. A capital account balance for a practice that doesn't carry goodwill on its books may significantly understate the economic value of a partner's interest. Practices with substantial patient relationships and referral infrastructure may be worth 2–4× their book value to a strategic buyer.
2. Whether capital accounts include or exclude ASC equity. Many ortho groups hold their practice equity and ASC equity in separate legal entities. If the ASC is a separate LLC, the partnership agreement may govern only the practice entity — and the ASC operating agreement governs separately. You may need to read both documents to understand your full ownership picture.

Governance and voting rights

Most partnership agreements distinguish between three categories of decisions by required vote threshold:

Understand specifically what vote percentage is required to (a) sell the practice or ASC, (b) admit new partners who dilute your interest, and (c) force a capital call. These are the three governance provisions with the largest financial impact on a minority partner.

Distribution waterfall and timing

How and when money flows from the partnership to individual partners is specified in the agreement's distribution provisions. The key questions:

Frequency

Most ortho groups distribute monthly or quarterly. Some defer distributions until annual reconciliation. If you're buying into a group with quarterly distributions, model your personal cash flow accordingly — especially early in the buy-in when you're still servicing financing for the buy-in cost.

Distribution formula

Distributions can be structured as equal splits (less common), pro-rata by equity percentage, or productivity-weighted by individual wRVU production or collections. Productivity-weighted models favor high-volume surgeons but create variation across partners. Confirm whether the formula can be changed by majority vote — and whether a new high-volume partner admitted after you could effectively shift the split against you.

Preferred return on ASC equity

In some groups, the ASC LLC distributes separately from the practice entity, with a preferred return to founding partners who took on the development risk. If you're joining an established group with a mature ASC, confirm whether founding partners receive a preferred return from ASC distributions before the general waterfall applies to your units.

ASC equity integration: the most ortho-specific provision

Orthopedic group partnerships are unusual compared to most professional practice agreements because they often involve two distinct equity interests: the clinical practice and the affiliated ambulatory surgery center. These may be held in the same legal entity or structured as separate LLCs — and the financial and legal treatment differs significantly.

The Anti-Kickback Statute Safe Harbor

Surgeon ownership in an ASC qualifies for the Anti-Kickback Statute Safe Harbor under 42 C.F.R. § 1001.952(r) only if, among other conditions, the investor is a physician who derives at least one-third of medical practice income from procedures performed at the ASC, and the ASC does not discriminate in referrals based on investment status.¹ This Safe Harbor requirement is why ASC operating agreements typically restrict transfers to physicians who will actually operate cases at the facility — not passive investors.

Practical implication: when you eventually leave the group, your ASC equity is usually not freely transferable. The operating agreement typically gives the remaining partners a right of first refusal to buy you out, and the buyout formula is set in the agreement — not at a market price you negotiate at exit.

What to look for in ASC equity provisions

• Transfer restrictions. Can you sell ASC units to an outside surgeon you recruit? To a corporate buyer? Most agreements restrict to existing partners or approved new physician-investors.
• Redemption formula on departure. Is it book value (asset cost minus depreciation — likely very low for an established facility), a multiple of trailing distributions, or a formula based on the ASC's appraised fair market value? The redemption formula is the most financially consequential single clause for a surgeon who eventually leaves.
• Case volume minimums. Some ASC operating agreements require physician partners to maintain a minimum case volume at the facility. If volume declines due to age, injury, or reduced practice, a case volume covenant can trigger a forced redemption — potentially at the below-market formula price at exactly the wrong time.
• Step-down provisions. Well-drafted agreements include step-down provisions that reduce a surgeon's equity stake as they approach retirement, rather than forcing full redemption. This preserves some ongoing distributions while allowing the group to manage succession.

Non-compete and non-solicitation within the group

Employment non-competes (surgeon vs. employer) are broadly covered in the non-compete clause guide. Partnership agreements contain a distinct version of these provisions — partner vs. partner — with different legal treatment and practical stakes.

When you leave a partnership, the partnership agreement typically includes:

• Geographic non-compete: Similar structure to employment non-competes (radius, duration, specialty scope), but under partnership law rather than employment law. Courts generally apply slightly different standards — partnerships have a legitimate interest in protecting goodwill and referral relationships built by all partners collectively.
• Non-solicitation of patients and referrers: Prohibits you from actively contacting former patients or the primary care and specialist referrers who directed patients to the group. Violating this can expose you to damages for profits diverted from the group.
• Non-solicitation of employees: Prohibits recruiting the group's staff to a competing practice. More commonly enforced than patient non-solicitations because the damages are easier to quantify.
• Confidentiality of financial information: Partnership financial data — distributions, wRVU benchmarks, payer contracts, ASC distributions — is typically confidential. This restricts what you can share when recruiting a new partner or negotiating with a PE buyer independently.

Buy-sell provisions: disability, death, retirement, and voluntary exit

Buy-sell provisions govern what happens to your equity in each departure scenario. Each scenario typically triggers a different economic outcome:

Disability

If you become unable to operate, most agreements provide a transition period (typically 12–18 months) during which you retain some distribution rights and your disability insurance benefit provides income replacement. After the transition period, the remaining partners buy out your interest — usually at the agreement's redemption formula. Confirm whether the buyout is funded by the group's key-person disability policy or comes from available cash/financing. An unfunded buyout in a capital-constrained group can delay your redemption payment for years.

See the disability insurance guide for how own-occupation coverage interacts with the partnership's disability provisions.

Death

Death triggers an immediate buyout obligation to the surgeon's estate. Well-designed partnership agreements fund this through a cross-purchase life insurance arrangement (each partner insures every other partner) or an entity-purchase arrangement (the group holds policies on all partners). The cross-purchase structure typically provides better income tax basis treatment to the surviving partners at exit. Confirm that the policy amounts are reviewed annually — a group that bought $1M policies ten years ago and whose members' equity is now worth $3M each is carrying unfunded gap risk that the estate will bear.

See the life insurance guide for the cross-purchase vs. entity-redemption tax comparison.

Retirement

Planned retirement usually triggers the most favorable terms: advance notice periods (typically 12–24 months), phased buyout of equity over 2–4 years, and continuation of partial distributions during the transition period. Confirm whether the retirement provision requires good standing (no active malpractice or disciplinary matters) and whether you must continue covering call during the notice period.

Voluntary exit (resignation)

Voluntary resignation typically triggers the least favorable economic terms — the redemption formula applies at the lowest possible valuation, non-compete provisions activate immediately, and the group has no obligation to facilitate the transition. If you leave voluntarily and the agreement specifies a book-value redemption formula, you may receive significantly less than the economic value you've built over a partnership tenure.

Capital call provisions

A capital call requires existing partners to contribute additional capital — for a new ASC facility, a robotics system, a real estate acquisition, or working capital. Most partnership agreements authorize capital calls by a majority or supermajority vote of the partners.

What to verify:

• What vote percentage authorizes a capital call? If a simple majority suffices, four of seven partners can require you to write a $200K check for a new ASC expansion you voted against.
• Is there a cap on the amount? Some agreements cap individual partner capital call obligations at a specific dollar amount per year or per transaction.
• What happens if you can't or won't fund? Failure to fund a capital call typically allows the group to dilute your equity proportionally (giving the funding partners a larger share) or, in some agreements, to force a redemption of your interest at a discounted formula price. Understand the consequence before you decline a call.
• How are capital calls financed? Well-structured groups arrange group-level financing for large capital investments (SBA 504, equipment loans) so that partners aren't required to fund personally. If the agreement relies on direct capital calls rather than entity-level financing for major projects, ask why.

Private equity and acquisition provisions

Orthopedic practices are among the most actively acquired surgical specialties by private equity. If your group receives a PE approach — or if current partners are planning an exit — the partnership agreement determines what you can be compelled to do.

Drag-along rights

A drag-along clause lets the majority sell the entire group — including your interest — if a specified percentage votes to proceed. If the agreement has a drag-along at 67%, six of nine partners can force the remaining three to sell their equity to the PE buyer at whatever price and terms the majority negotiated. You cannot block the transaction.

What to negotiate: a minimum drag-along price floor that protects minority partners from an underpriced deal; or a requirement that the same consideration per unit applies to all partners, preventing side arrangements that pay founders more.

Tag-along rights

Tag-along rights work in the opposite direction: if a majority of partners want to sell their interests to a buyer, minority partners have the right to participate in the sale at the same price per unit, rather than being left behind in a now-PE-controlled entity without liquidity. Tag-along rights protect small equity holders from being stranded after a partial sale changes the group's ownership structure.

Right of first refusal (ROFR)

Most partnership agreements give the group or existing partners the right to buy departing partners' interests before they are sold to outside parties. A ROFR at formula price effectively caps a departing partner's realization — even if an outside buyer would pay more. Some agreements allow the departing partner to accept an outside offer only if the group declines to match it within a specified window (typically 30–60 days). Understand whether the ROFR applies at formula price or at the offered outside price.

Rollover equity and continued employment on PE sale

In a PE transaction, surgeons typically receive 70–80% of deal proceeds in cash and retain 20–30% as rollover equity in the new PE-controlled entity — subject to vesting over 3–5 years and tied to continued employment. Your continued employment terms, non-compete scope, and rollover equity vesting schedule are all subject to negotiation before you sign the PE employment agreement. Once you've agreed to sell, your leverage diminishes. Review the practice sale guide for the full transaction structure analysis.

What to negotiate before you sign

The partnership agreement negotiation is separate from the employment contract negotiation. Prioritize these provisions:

1. Redemption formula. Push for fair market value appraisal (independent appraiser, cost-split) as an option at voluntary exit, not just book value. This single provision can mean a $500K–$2M difference in what you receive when you eventually leave.
2. Anti-dilution protection. Require supermajority approval (not simple majority) to admit new partners who dilute your interest.
3. Capital call cap. Negotiate a per-event or annual cap on capital call obligations, or require entity-level financing as the primary funding mechanism before partners are called.
4. Drag-along threshold. Push the drag-along threshold as high as possible — 75–80% — to give minority partners more protection against forced sales.
5. Disability funding. Confirm that disability buyout obligations are funded by group insurance (or self-insurance reserve), not just an IOU from the remaining partners.
6. ASC redemption terms. Negotiate the ASC operating agreement buyout formula at the same time as the practice agreement. The ASC formula often matters more financially than the practice formula.

Red flags in partnership agreement language

• Book value only as the redemption formula with no appraisal alternative. Established practices have goodwill that book value doesn't capture. A surgeon who spends 15 years building referral relationships should not be redeemed at depreciated equipment value.
• Drag-along at simple majority (51%). A bare majority can force a full practice sale. Minority partners have essentially no protection against a PE deal they oppose.
• Capital calls with no dollar cap and no financing-first requirement. Open-ended personal capital call obligations for unlimited amounts are high-risk provisions, particularly in a group making aggressive ASC expansion plans.
• "Agreement may be amended by majority vote." If the majority can rewrite the agreement without your consent, every protection you negotiated can be changed after you're in. Push for supermajority requirements to amend any provision that affects individual partner economics.
• No funded disability buy-sell mechanism. If the agreement requires your interest to be bought out at disability but doesn't specify funding source, you may wait years for payment — at which point the disability insurance own-occupation benefit has been paying out and you need the capital.
• Non-compete that covers both the employment relationship AND the partnership. Two separate non-compete obligations (employment and partnership) in different legal documents can create overlapping and potentially conflicting restrictions. Have an attorney reconcile them before you sign either.

Getting the analysis right

The buy-in financial analysis and the partnership agreement review should happen simultaneously, not sequentially. The financial model tells you whether the economics work under normal conditions. The agreement tells you what happens when conditions change — and conditions always change over a 20-year partnership tenure.

A fee-only financial advisor who specializes in orthopedic practice economics can:

• Model the full distribution trajectory incorporating the agreement's specific waterfall and allocation formula
• Stress-test the redemption formula at different exit scenarios (voluntary, disability, PE acquisition)
• Quantify the capital call risk exposure under the agreement's voting thresholds
• Coordinate the buy-in analysis with the ASC operating agreement review so you understand your combined equity picture before committing
• Identify which provisions are standard and which are unusual compared to current market terms for ortho group partnerships

Use the partnership buy-in analyzer to model the baseline economics, the ASC investment calculator for the ASC equity return, and the advisor selection guide to find the right specialist before you sign.

1. 42 C.F.R. § 1001.952(r) — Anti-Kickback Statute Safe Harbor for Ambulatory Surgical Centers. Federal register requirements for ASC physician-investor Safe Harbor, including procedure-income test and anti-discrimination requirements.
2. AAOS Practice Management Resources — Private Practice. American Academy of Orthopaedic Surgeons guidance on private practice governance and partnership structures.
3. ASC Physician Ownership Models — ASCA ASC Focus. Ambulatory Surgery Center Association analysis of physician ownership structures and operating agreement frameworks.
4. Physician Buy-Sell Agreements — MGMA. MGMA guidance on buy-sell agreement design for medical groups, including funding mechanisms and valuation standards.
5. Physician Group Partnership Agreements — American Health Law Association. Healthcare legal framework for physician group governance, including voting rights, capital accounts, and redemption standards.

Partnership agreement structures evolve with practice law, tax regulation, and PE market dynamics. Retain a healthcare transactional attorney licensed in your state for any specific agreement. Legal and structural information verified as of June 2026.